179 related articles for article (PubMed ID: 6753245)
21. Radiotherapy in supratentorial gliomas. A study of 821 cases.
Heesters M; Molenaar W; Go GK
Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126
[TBL] [Abstract][Full Text] [Related]
22. Clinical trials of misonidazole in the United States.
Wasserman TH; Stetz J; Phillips TL
Cancer Clin Trials; 1981; 4(1):7-16. PubMed ID: 7214664
[TBL] [Abstract][Full Text] [Related]
23. Preliminary results of RTOG phase I/II study of misonidazole and radiation for bladder cancer.
Mohiuddin M; Kramer S; Phillips T; Soberon M; Forgione H
Am J Clin Oncol; 1982 Oct; 5(5):551-4. PubMed ID: 7180834
[TBL] [Abstract][Full Text] [Related]
24. [Clinical experiences with the radiosensitizer Misonidazol (author's transl)].
Bamberg M; Tamulevicius P; Streffer C; Scherer E
Strahlentherapie; 1981 Aug; 157(8):524-36. PubMed ID: 7268822
[No Abstract] [Full Text] [Related]
25. Meta-analytic re-evaluation of misonidazole in the treatment of high grade astrocytoma.
Huncharek M
Anticancer Res; 1998; 18(3B):1935-9. PubMed ID: 9677447
[TBL] [Abstract][Full Text] [Related]
26. Misonidazole peripheral neuropathy: its relationship to plasma concentration and other drugs.
Walker MD; Strike TA
Cancer Clin Trials; 1980; 3(2):105-9. PubMed ID: 6253094
[TBL] [Abstract][Full Text] [Related]
27. Fast neutrons and misonidazole for malignant astrocytomas.
Kurup PD; Pajak TF; Hendrickson FR; Nelson JS; Mansell J; Cohen L; Awschalom M; Rosenberg I; Ten Haken RK
Int J Radiat Oncol Biol Phys; 1985 Apr; 11(4):679-86. PubMed ID: 2984151
[TBL] [Abstract][Full Text] [Related]
28. [Clinical testing of the radiosensitizer RO-07-0582 (misonidazole). Dose tolerance, toxicity and pharmacokinetic studies, preliminary report (author's transl)].
Bataini JP; Bernier J; de Narbonne J; Brugère J; Jaulerry C; Brunin F
Bull Cancer; 1978; 65(4):482-5. PubMed ID: 371710
[No Abstract] [Full Text] [Related]
29. Misonidazole in the clinic at Mount Vernon.
Dische S
Cancer Clin Trials; 1980; 3(2):175-8. PubMed ID: 7000388
[TBL] [Abstract][Full Text] [Related]
30. The Cambridge glioma trial of misonidazole and radiation therapy with associated pharmacokinetic studies.
Bleehen NM
Cancer Clin Trials; 1980; 3(3):267-73. PubMed ID: 7002338
[TBL] [Abstract][Full Text] [Related]
31. Hypofractionated high-dose irradiation for the treatment of malignant astrocytomas using simultaneous integrated boost technique by IMRT.
Iuchi T; Hatano K; Narita Y; Kodama T; Yamaki T; Osato K
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1317-24. PubMed ID: 16580493
[TBL] [Abstract][Full Text] [Related]
32. Clinical experience with misonidazole: high dose fractions versus daily low doses.
Kogelnik HD
Cancer Clin Trials; 1980; 3(2):179-86. PubMed ID: 6253098
[TBL] [Abstract][Full Text] [Related]
33. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
Mizoe JE; Tsujii H; Hasegawa A; Yanagi T; Takagi R; Kamada T; Tsuji H; Takakura K;
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):390-6. PubMed ID: 17459607
[TBL] [Abstract][Full Text] [Related]
34. Should radiotherapy for low-grade glioma be given immediately after surgery or at the time of progression?
Rosenfeld MR
Nat Clin Pract Neurol; 2006 Mar; 2(3):128-9. PubMed ID: 16932536
[No Abstract] [Full Text] [Related]
35. Adult brain low-grade astrocytomas: survival after surgery and radiotherapy.
Arienti VM; Botturi A; Boiardi A; Broggi G; Collice M; Fariselli L; Zanni D; Botturi M
Neurol Sci; 2001 Jun; 22(3):233-8. PubMed ID: 11731876
[TBL] [Abstract][Full Text] [Related]
36. Postoperative radiotherapy results in primary spinal cord astrocytomas.
Zorlu F; Ozyigit G; Gurkaynak M; Soylemezoglu F; Akyol F; Lale Atahan I
Radiother Oncol; 2005 Jan; 74(1):45-8. PubMed ID: 15683668
[TBL] [Abstract][Full Text] [Related]
37. Experience with carbon ion radiotherapy for WHO Grade 2 diffuse astrocytomas.
Hasegawa A; Mizoe JE; Tsujii H; Kamada T; Jingu K; Iwadate Y; Nakazato Y; Matsutani M; Takakura K;
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):100-6. PubMed ID: 22104357
[TBL] [Abstract][Full Text] [Related]
38. Recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2) immunotherapy with ranimustine chemotherapy and concurrent radiation therapy for malignant astrocytomas.
Fukushima T; Yamamoto M; Oshiro S; Tsugu H; Hirakawa K; Soma G
Anticancer Res; 2003; 23(6a):4473-81. PubMed ID: 14666736
[TBL] [Abstract][Full Text] [Related]
39. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
40. Clinical studies with misonidazole.
Wiltshire CR; Workman P; Watson JV; Bleehen NM
Br J Cancer Suppl; 1978 Jun; 3():286-9. PubMed ID: 277246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
